Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly
Delfina Janiri, Martina Petracca, Lorenzo Moccia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Narayanappa Amruta, Wesley H. Chastain, Meshi Paz, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 58, pp. 1-15
Open Access | Times Cited: 117
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 45
Impacts of COVID-19 Pandemic on Psychological Well-Being of Older Chronic Kidney Disease Patients
Alex Siu Wing Chan, Jacqueline Mei Chi Ho, Jane Siu Fan Li, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 49
Neurological toll of COVID-19
Shivam Bhola, Jhillika Trisal, Vikram Thakur, et al.
Neurological Sciences (2022) Vol. 43, Iss. 4, pp. 2171-2186
Open Access | Times Cited: 37
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
Edoardo Bianchini, Camilla Onelli, Carmen Morabito, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 31
Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review
Samantha K. Brooks, Dale Weston, Neil Greenberg
Public Health (2021) Vol. 199, pp. 77-86
Open Access | Times Cited: 36
Reduced Hedonic Tone and Emotion Dysregulation Predict Depressive Symptoms Severity during the COVID-19 Outbreak: An Observational Study on the Italian General Population
Lorenzo Moccia, Delfina Janiri, Giulia Giuseppin, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 18, Iss. 1, pp. 255-255
Open Access | Times Cited: 36
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Lea Krey, Meret K. Huber, Günter U. Höglinger, et al.
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1654-1654
Open Access | Times Cited: 28
Post-COVID-19 Psychiatric Symptoms in the Elderly: The Role of Gender and Resilience
Delfina Janiri, Matteo Tosato, Alessio Simonetti, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 2016-2016
Open Access | Times Cited: 21
Psychopathological burden and coping strategies among frontline and second-line Italian healthcare workers facing the COVID-19 emergency: Findings from the COMET collaborative network
Gabriele Sani, Delfina Janiri, Lorenzo Moccia, et al.
Journal of Affective Disorders (2022) Vol. 311, pp. 78-83
Open Access | Times Cited: 19
Dementia and Mental Health During the COVID-19 Pandemic: A Systematic Review
Julia Gaigher, Isabel Barbeito Lacerda, Márcia Cristina Nascimento Dourado
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 19
Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease
Bradley McDaniels, Indu Subramanian
International review of neurobiology (2022), pp. 197-227
Open Access | Times Cited: 16
Mental health in people with Parkinson’s disease during the COVID-19 pandemic: potential for targeted interventions?
Lisanne J. Dommershuijsen, Anouk van der Heide, Eija Berg, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Parkinson’s Disease, SARS-CoV-2, and Frailty: Is There a Vicious Cycle Related to Hypovitaminosis D?
Sara Palermo, Mario Stanziano, Anna Nigri, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 528-528
Open Access | Times Cited: 7
Psychological outcomes of the COVID-19 pandemic in patients with Parkinson’s disease: A systematic review
Fardin Nabizadeh, Zahrasadat Seyedalhosseini, Mohammad Balabandian, et al.
Journal of Clinical Neuroscience (2022) Vol. 102, pp. 101-108
Open Access | Times Cited: 11
The mental health impacts of the COVID-19 pandemic among individuals with depressive, anxiety, and stressor-related disorders: A scoping review
Christine M. Wickens, Veda Popal, Venesa Fecteau, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295496-e0295496
Open Access | Times Cited: 6
Worsened Parkinson’s Disease Progression: Impact of the COVID-19 Pandemic
Christian Ineichen, Heide Baumann‐Vogel, Matthias Sitzler, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1579-1583
Open Access | Times Cited: 15
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia
Natasha Irrera, María Antonietta Barbieri, Gianluca Bagnato, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 21, Iss. 10, pp. 1017-1026
Closed Access | Times Cited: 10
Efectos del aislamiento en adultos mayores durante la pandemia: una revisión de la literatura
Alexandra Granda-Oblitas, Gema Ximena Quiroz Gil, Fernando Miguel Runzer Colmenares
ACTA MEDICA PERUANA (2022) Vol. 38, Iss. 4
Open Access | Times Cited: 10
The Impact of the COVID-19 Pandemic on Informal Caregivers of People With Parkinson’s Disease Residing in the UK: A Qualitative Study
Daniel Rippon, Annette Hand, Lorelle Dismore, et al.
Journal of Geriatric Psychiatry and Neurology (2022) Vol. 36, Iss. 3, pp. 233-245
Open Access | Times Cited: 9
Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study
Andreas Wolff, Bernhard Haller, Antonia F. Demleitner, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 353-353
Open Access | Times Cited: 8
Quality of life and Concerns of Parkinson's Disease Patients and their Caregivers during COVID-19 Pandemic
Sourav Banerjee, Adreesh Mukherjee, Bidisha Bhattacharyya, et al.
Annals of Indian Academy of Neurology (2022) Vol. 25, Iss. 4, pp. 676-682
Open Access | Times Cited: 7
Impact of COVID‐19 pandemic on patients with Parkinson's disease: A meta‐analysis of 13,878 patients
Aaron Shengting, Jung Hahn Yong, Brendan Jen‐Wei Tan, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1504-1513
Open Access | Times Cited: 7
Management of Parkinson’s Disease in the COVID-19 Pandemic and Future Perspectives in the Era of Vaccination
Yue Hui Lau, Keng Ming Lau, Norlinah Mohamed Ibrahim
Journal of Movement Disorders (2021) Vol. 14, Iss. 3, pp. 177-183
Open Access | Times Cited: 9
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease
Sabrina Poonja, К. Ray Chaudhuri, Janis M. Miyasaki
Current Opinion in Neurology (2022) Vol. 35, Iss. 4, pp. 494-501
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top